Article
Influence of the shared epitope on the effectiveness of biologic antirheumatic agents in European patients with rheumatoid arthritis.
RMD open - 9 Jul 2026
Finckh Axel, Courvoisier Delphine S, Aymon Romain, Mongin Denis, Saevarsdottir Saedis, Jonsdottir Ingileif, Stefansson Kari, Hetland Merete Lund, Moeller Burkhard, Villard Jean, Lauper Kim, Glintborg Bente
Abstract excerpt
BACKGROUND: For rheumatoid arthritis (RA), the HLA-DRB1 'shared epitope' (SE) allele has been proposed as a predictive biomarker for the effectiveness of mainly abatacept and other biologic disease-modifying antirheumatic drugs (bDMARDs). OBJECTIVE: To explore the relative impact of SE positivity on the effectiveness of different bDMARDs in European patients with RA. METHODS: Nested cohort study in the Swiss...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
